Literature DB >> 1847991

Paraneoplastic vasculitic neuropathy: a treatable neuropathy.

S J Oh1, R Slaughter, L Harrell.   

Abstract

Paraneoplastic vasculitic neuropathy has been recently described. We report the first case of this disorder which responded both clinically and electrophysiologically to cyclophosphamide treatment. A 54-year-old woman with a history of metastatic endometrial carcinoma in remission had asymmetrical polyneuropathy, electrophysiological findings consistent with a diffuse axonal neuropathy, high sedimentation rate and spinal fluid protein, and microvasculitis with axonal degeneration on nerve biopsy. The patient was treated with 150 mg of cyclophosphamide daily with gradual clinical and electrophysiological improvement.

Entities:  

Mesh:

Year:  1991        PMID: 1847991     DOI: 10.1002/mus.880140210

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  12 in total

Review 1.  A review of the therapy of paraneoplastic neurologic syndromes.

Authors:  A Das; F H Hochberg; S McNelis
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Progress in the management of paraneoplastic neurological disorders.

Authors:  Hamid Sadeghian; Steven Vernino
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

3.  Lymphoma, paraproteinaemia, and neuropathy.

Authors:  J H Wokke; J H Morris; M Donaghy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

Review 4.  Diagnosis and therapeutic options for peripheral vasculitic neuropathy.

Authors:  Franz Blaes
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-04       Impact factor: 5.346

5.  Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies.

Authors:  J C Antoine; J F Mosnier; L Absi; P Convers; J Honnorat; D Michel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-07       Impact factor: 10.154

6.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

7.  Immunomodulatory treatment trial for paraneoplastic neurological disorders.

Authors:  Steven Vernino; Brian Patrick O'Neill; Randolph S Marks; Judith R O'Fallon; David W Kimmel
Journal:  Neuro Oncol       Date:  2004-01       Impact factor: 12.300

8.  Chronic idiopathic axonal polyneuropathy: a five year follow up.

Authors:  N C Notermans; J H Wokke; Y van der Graaf; H Franssen; G W van Dijk; F G Jennekens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

Review 9.  Paraneoplastic rheumatic syndromes.

Authors:  H J Mitnick
Journal:  Curr Rheumatol Rep       Date:  2000-04       Impact factor: 4.686

10.  Endometrial carcinoma presenting as vasculitic sensorimotor polyneuropathy.

Authors:  Marketa Vasku; Thomas Papathemelis; Nicolai Maass; Ivo Meinhold-Heerlein; Dirk Bauerschlag
Journal:  Case Rep Obstet Gynecol       Date:  2011-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.